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Abstract
Animals as model organisms, the silent sentinels, stand watch over the environ-
mental health of the world. These are non-human animal species which can be used 
to understand specific biological processes and to obtain informations which can 
provide an insight into working of other organisms. Among the model organisms, 
the zebrafish (Danio rerio) is one of the best leading models to study developmental 
biology, cancer, toxicology, drug discovery, and molecular genetics. In addition, the 
zebrafish is increasingly used as a genetic model organism for aquaculture species 
and in toxicogenomics and also to generate zebrafish disease models for application 
in human biomedicines. This tiny fish is a versatile model organism for many fields 
of research because of its easy maintenance, breeding, and transparent body during 
early development.
Keywords: model organisms, zebrafish, biological process, developmental biology, 
cancer, toxicology, drug discovery
1. Introduction
Zebrafish (Danio rerio) is a prominent model organism in biological researches 
in recent times. Zebrafish is a tropical freshwater fish, inhabitant of rivers (Ganges 
mainly) of Himalayan region of South Asia especially India, Nepal, Bhutan, 
Pakistan, Bangladesh, and Myanmar. It is a bony fish (teleost) that belongs to the 
family Cyprinidae under the class Actinopterygii (ray-finned fishes).
Zebrafish was first used as a biological model by George Streisinger (University 
of Oregon) in the 1970s because it was simpler over mouse and easy to manipulate 
genetically. Streisinger’s colleagues especially Chuck Kimmel in his university got 
much impressed by the idea of using zebrafish embryo more attractive to study the 
development of nervous system.
The use of zebrafish as a model organism got impetus from the 1990s when 
it was used to develop two large genetic mutants, one by Nobel Prize winner 
Christiane Nusslein-Volhard in Tubingen, Germany, and the other by Wolfgang 
Driever and Mark Fishman in Boston, USA. The identification of mutants is one of 
the most important strategies for the study in various areas of biology.
Zebrafish has a lot of physiological and genetic similarities with humans, includ-
ing the brain, digestive tract, musculature, vasculature, and innate immune system 
[1–7]. Also 70% of human disease genes have functional similarities with those of 
zebrafish [8].
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1.1 Salient features of zebrafish as a model organism
D. Rario is preferred by scientists because of its variety of features that make 
it useful as a model organism. The embryo develops rapidly outside mother and 
optically clear and thus, easily accessible for experimentation and observation. The 
embryo develops very fast, and the blastula stage lasts only for 3 h, while gastrula-
tion gets completed in 5 h; in an embryo that is about 18 h old, very well developed 
ears, eyes, segmenting muscles, and brain can be viewed as the embryo is transpar-
ent. By 24 h, segmentation gets completed, and most primary organ systems are 
formed. By 72 h, the embryo hatches out from the eggshell and within the next 2 
days starts hunting for food. In a period of just 4 days, the embryo converts rapidly 
into a small version of adult. The rapid development simplifies development and 
genetic studies.
The adult zebrafish attains sexual maturity very quickly, having generation time 
of about 10 weeks, and also this tiny fish has good fecundity rate. When kept under 
optimal conditions, the zebrafish can lay about 200 eggs per week [9, 10]. Under 
laboratory conditions the zebrafish can spawn throughout the year that ensures the 
constant supply of offspring from designated pairs that makes this transparent fish 
a quintessential choice for large-scale genetic approaches to identify novel genes 
and to discover their specific functions in vertebrates [11]. The zebrafish is a very 
hard fish and is very easy to raise.
In addition to the features of zebrafish mentioned above, it requires very low 
space and maintenance cost. These features make this fish an attractive model 
organism for developmental, toxicological, and transgenic studies [12].
In this chapter author summarizes some of the recent advances in the area of 
zebrafish research, viz., developmental biology, toxicology, transgenic studies, 
human disease, drug discovery, cancer, etc. This review is by no means a compre-
hensive one but an attempt to provide a flavor to the readers some recent advances 
about this wonderful creature to use in potential researches.
2. Use of zebrafish in developmental biology
Much of the pioneer works that established zebrafish as a model organism were 
done by George Streisinger, Charles Kimmel, and their colleagues [13]. The team 
of these researchers studied the embryonic axis, cell lineage analysis, embryonic 
formation, development of central and peripheral nervous systems, muscle devel-
opment, differential regulation of gene expression, etc. [14–16].
Many of the critical pathways that control development in vertebrates are highly 
conserved between human and zebrafish. The zebrafish genome shares a lot of 
similarities with human genome. About 70% of genes associated with disease in 
humans have functional homologs in zebrafish [8]. Realizing the importance of 
zebrafish model, Grunwald and Eisen used this developmental model to study the 
segmental structure of the brain and characterized neurons in zebrafish for the 
first time in a vertebrate model [17]. Nüsslein-Volhard recognized the importance 
of zebrafish as a vertebrate model to study developmental biology by identifying 
developmentally important genes [18]. The zebrafish model has been used to see the 
development of various systems/processes as follows.
2.1 Development of the enteric nervous system
Recently advances have been made to study the development of the enteric ner-
vous system (ENS) using the zebrafish model. Like other vertebrates, the zebrafish 
3Zebrafish (Danio rerio) as a Model Organism
DOI: http://dx.doi.org/10.5772/intechopen.81517
gastrointestinal tract is a complex organ composed of multiple cell types like 
epithelial, muscular, vascular, neural, and immune cells. The gut of the zebrafish 
(teleost) and amniotes have structural similarities, but in teleost it is less complex 
as compared to amniotes [19]. The zebrafish GI tract has no distinct stomach but 
an enlarged area of the anterior intestine that is known as the intestinal bulb. This 
intestinal bulb displays patterns of motility as well as goblet cells that produce acid 
and neutral mucins like the stomach of mammals [20, 21]. The gut epithelium of 
zebrafish is simpler than that of amniotes; it lacks crypts and is arranged in an 
irregular broad fold rather than forming villi [21, 22]. The genes (sox2, barx1, gata5, 
and gata6) which are responsible for the formation of the stomach of zebrafish also 
resemble with that of amniotes [23].
Like that of all vertebrates, the enteric nervous system of zebrafish is also 
derived from neural crest [24], but it differs potentially from amniotes wherein the 
enteric nervous system is derived from both the vagal and sacral crests, while in 
the case of zebrafish, it is derived from the vagal crest only [25–28]. Enteric neural 
crest cell (ENCC) migration along the gut in zebrafish is also similar with that in 
amniotes. It takes place in two parallel chains along the length of the developing 
gut [25, 27, 28]. Afterward the precursors of the ENS voyage circumferentially 
around the gut and differentiate into the enteric neuron and glia. The final organi-
zation of the zebrafish ENS is also very simple as compared to that of amniotes; it 
is composed of single neuron or small group of neurons rather than more complex 
ganglionated myenteric and submucosal plexuses [27, 29].
2.2 Angiogenesis
Zebrafish model also has been used in the study of angiogenesis and regenera-
tion. Angiogenesis is the process through which new blood vessels originate from 
preexisting vascular structures which play essential role in healthy physiological 
and pathological conditions. It is achieved through interaction between endothelial 
cells and their niche. Inadequate maintenance leads to the development of many 
disorders like tissue ischemia, inflammatory disorders, retinopathies, excessive 
vascular growth, or abnormal remodeling that promotes cancer [30].
Being a transparent vertebrate, the zebrafish has emerged as a convenient 
alternative to study the early development of the cardiovascular system and 
observe the flow of blood [31]. In zebrafish larvae the vessels and blood flow 
can easily be visualized by using simple dissecting microscope and also by using 
fluorescent proteins; the development of the blood vascular system could be 
examined in great details. By using confocal microscopy and time-lapse imaging, 
the detailed morphogenetic movements and cell shape changes can be carried out 
in live specimens [31].
Vascular anatomy development of zebrafish using molecular tracers during early 
embryonic stages has high level of similarities with other vertebrates [1, 32, 33]. In 
one of the experiments, the injected fluorescent microsphere was detected when 
lumenization and anastomosis of the vascular network were complete [34]. The 
same approach was adopted to compare the development of blood and lymphatic 
vasculatures in zebrafish [35]. The individual cell growth during vascular develop-
ment also can be tracked.
For vascular development and growth, angiogenesis plays a very important 
role. During embryonic development, the intersegmental vessels are formed by 
angiogenic sprouting from the dorsal aorta, and they have been the target of studies 
using genetic perturbations or drugs [36]. It has been reported that mammalian 
malignant cells can be xenotransplanted into zebrafish embryos, and they can form 
tumors [37], and thus models for tumor angiogenesis have been developed [38].
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2.3 Regeneration
The zebrafish exhibits remarkable capacity of regeneration even in adult stages. 
The caudal fin especially provides an ideal tissue for vascular regeneration stud-
ies due to its simple and fine architecture and relative transparency [39]. After 
successive amputations the full regeneration of the caudal fin used to take place 
within couple of weeks [40]. The regenerating vessels in the regenerating caudal 
fin originate from vein-derived cells that have angiogenic potential [41]. These 
cells migrate individually or in groups and assemble into the vessel in response to 
chemokine signaling [42].
The zebrafish as an alternative model for angiogenesis and regeneration studies 
provides the relevance of in vivo assays with simplicity and versatility of in vitro 
assays. In larvae, access to developing vasculature through fluorophore-tagged 
strains and small size of zebrafish makes the use of high-throughput strategies pos-
sible. In adults, the caudal fin is equally convenient as a model tissue as regenerating 
vessels can be observed at all stages, and the animals (zebrafish) are suitable for 
experimental drug manipulations [31].
3. Zebrafish as a cancer model system
Cancer is a cursed reality for millions of humans worldwide and in fact for all 
vertebrates. The invertebrates such as flies and nematodes also can develop anoma-
lies in cell proliferation. Clinically and pathologically this dreaded disease is present 
almost exclusively in all vertebrates, from fish to humans. To understand better the 
formation, growth, and spread of malignant tumors, vertebrate models are impera-
tive. Being a vertebrate the zebrafish is an ideal model to study cancer, though 
humans and fishes are separated from their common ancestry but biology of the 
cancer in both groups of organisms is the same [43]. Because of the variety of ben-
efits to use zebrafish as a model organism which are mentioned in “Introduction,” 
the zebrafish is adroitly exploited to carcinogenic treatment, transplantation of 
mammalian tumor cells, and transgenic regulations [44].
3.1 Zebrafish as a model for carcinogen effects and development of cancer 
studies
Fishes are exposed to many waterborne carcinogens in the wild that lead to 
the development of a variety of benign and malignant tumors in teleosts, and 
these tumors have similar histology as in humans [45, 46]. As like humans, 
cancer is a genetic disease in fishes as shown by melanomas which develop in 
Xiphophorus hybrids [47]. Choosing zebrafish for modeling cancer studies has 
many advantages. Highly conserved cancer pathways can be screened genetically 
using zebrafish. Primarily cancer is a disease of adults, but through mutagenesis 
screens, cell cycle phenotype could be examined in rapidly developing transpar-
ent embryos of the zebrafish. The genes regulating cell cycle, cell proliferation, 
and apoptosis have already been screened in yeast, Drosophila and C. elegans, in 
the similar way gene functions for these biological pathways can be screened in 
zebrafish to understand the events that lead to the development of cancer in any 
vertebrate species [43].
By inducing different gene mutations or stimulating signaling pathways through 
chemicals, the tumors can be induced in different organs of the zebrafish like the 
pancreas, liver, GI tract, vasculature, muscles, skin, and testes [46, 48–51]. It is 
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possible to identify the interacting oncogenes via suppressor and enhancer screens 
which cause the formation of specific type of tumor. The mammalian tumor cells 
can be transplanted into the zebrafish, dispensing a novel way to study the interac-
tions between transplanted tumor cell and vasculature of host.
3.2 Tumorigenesis
Tumorigenesis is a multistep process induced by chemical carcinogen [52], 
with accumulation of both epigenetic aberrations and mutations in regulatory 
regions of genes and disorder of signaling pathways [53, 54]. Methylation of DNA 
at CpG dinucleotides is an important component of epigenetic gene expression 
regulation [55] that causes the modulation of protein-DNA interactions [56, 57]. 
Aberrant methylation of CpG islands (CGT) takes place in the exonic and promoter 
regions [58, 59] and changes in gene expression associated with tumorigenesis. 
Hypermethylation of tumorigenetic genes has negative impact (regulation) over 
tumor suppressor genes (TSGs), DNA repair genes, and antiangiogenic genes, and 
it is a common quality of neoplastic cells [55, 60–63].
A variety of fishes have been used as model to study tumors induced by envi-
ronmental carcinogens. Among all the zebrafish proved best for investigating 
embryogenesis, organogenesis, and impact of environmental carcinogen for the 
development of cancer [64]. Chemically induced tumors in zebrafish and humans 
are histopathologically similar [43, 65], and orthologous oncogenes and tumor sup-
pressor genes (TSGs) have been identified in fishes and humans [65]. Hepatic gene 
expression in humans and zebrafish has revealed conservation of gene expression 
profiles at different stages of tumor aggressiveness between these two phylogeneti-
cally distant species [66, 67].
3.3 Xenotransplantation
Xenotransplantation represents another novel way to induce tumor in zebraf-
ish. The most important feature of xenotransplantation is that tumor cells can be 
stained/marked by fluorescent stain that distinguishes transplanted cells from 
normal cells and helps in clear observation of developmental process of the tumor 
[68]. Several other types of tumor, such as pancreatic cancer, lung cancer, ovarian 
carcinoma, breast cancer, prostate cancer, retinoblastoma, leukemia, etc., have also 
been transplanted in the zebrafish [7].
3.4 Angiogenesis
Angiogenesis is the most important factor in tumor growth and subsequent 
metastasis. The importance of angiogenesis has been discussed well in the previous 
section on development. The vascular network is helpful to transport oxygen and 
nutrients to the cells; likewise tumor cells also get the supply of all these materials. 
Because of this reason, the development and the capability of the formation of 
blood vessels within the tumor determine the malignancy of the cancer as well as 
influence the therapeutic effects and prognosis. The endothelial cells of the vascular 
system can be stained by fluorescent dye/protein that helps to visualize the neovas-
cularization of tiny tumor at the earliest stage, and metastasizing tumor cells can be 
tracked explicitly at cellular level [7]. The vascular system of tumor has always been 
the target of antitumor therapies; it is evident from research and clinical observa-
tions that if angiogenesis inhibitors are used in combination with chemotherapy, it 
can improve the outcome in cancer patients [69].
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3.5 Skin cancer
Skin or dermal cancers represent the most common type of cutaneous malignancy 
globally, which includes melanoma and carcinoma of squamous cells [70]. Melanoma 
is the most pernicious form of skin cancer among all types of skin cancers and has 
mortality rate over 80% [71, 72]. Melanoma usually develops in the pigmented 
epidermal cells (melanocytes), which are responsible for the production of melanin. 
In the beginning of melanoma, it is restricted to the epidermis because of the radial 
growth phase (RGP) of melanoma, and it can be removed by surgical excision [73]. 
In later stages of tumor progression, the melanoma cells invade the subcutaneous 
tissues due to vertical growth phase (VGP) of melanoma and eventually lead toward 
the metastatic phase. At this stage, very limited therapeutic options are available, and 
melanoma frequently deteriorates and becomes untreatable [73, 74].
Cutaneous squamous cell carcinoma (cSCC) mostly develops due to UV radia-
tion exposure of epidermal cells, namely, keratinocytes, in which uncontrolled pro-
liferation starts [75]. cSCC accounts for the most frequent type of non-melanoma 
cutaneous cancer and constitutes about 20% of all skin malignancies [75, 76].
SCCs are curable in situ by surgical excision. Metastatic SCCs are responsible for 
majority of deaths due to non-melanoma skin cancer [70]. Head and neck squamous 
cell carcinoma (HNSCC) develops in various places such as the oropharynx and 
laryngopharynx which is very common worldwide [77]. Especially oral squamous 
cell carcinoma (OSCC) accounts for about 24% of HNSCC with a mortality rate of 2 
million deaths every year [76, 78].
Zebrafish is a powerful in vivo tool to study pathologies and treatment for 
skin cancer (melanoma and SCC). The zebrafish can be used to study melanoma 
development, progression, drug screening, and treatment. The zebrafish model has 
been exploited recently to recognize the key molecules which are responsible for 
the development of cutaneous squamous cell carcinoma (cSCC) and head and neck 
squamous cell carcinoma (HNSCC) [72] as well as for SCC target therapies [79].
3.6 Tumor metastasis
Metastasis is a multistep and complex process in which tumor cells penetrate in 
the vascular system and spread deep in parenchymatous tissues [80]. For better ther-
apeutic practices like development of antitumor drugs and advancements of clinical 
treatments, the insight into mechanism of tumor metastasis is very helpful. Because 
of many significant disadvantages in the previous studies using in vivo mouse model, 
the metastasis process cannot be abstracted properly, but zebrafish cancer model has 
overcome the drawback of previous models and has shown exceptional strengths. 
The adaptive immune system in larvae of zebrafish usually develops after 14 DPF, 
which provides very conducive environment for survival of transplanted cancer cells 
and metastasis [81], and the process of tumor metastasis can be observed through 
the transparent body of zebrafish under microscope. To better understand the 
process of metastasis, the transplanted tumor cells can be stained/treated by dye like 
CM-Dil or may be labeled by red fluorescent protein (RFP) [82]. Mammalian tumor 
cells treated with red fluorescent protein when injected into transgenic zebrafish, the 
process of tumor cell metastasis and angiogenesis can be viewed well after 48 h  
of transplantation [83]. By using zebrafish, the suppressing or promoting factors 
for metastasis can be identified. In RFP treated U87 glioma stem cells (GSCs), when 
transplanted into the yolk sac of the zebrafish embryo, the various invasive stages of 
GSCs like approaching, cluster formation, invasion, migration, and transmigration 
can be observed clearly at 48 h postinjection [83].
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4. Toxicology and drug discovery
As discussed previously in Section 1, because of many advantages, the zebraf-
ish has recently emerged as a prominent model for toxicological studies and drug 
discovery. The effects of drugs on growth and development can be examined visu-
ally through length and shape of the zebrafish body as well as the morphology of 
internal organs such as the brain, liver, cardiovascular system, pancreas, intestine, 
kidney, notochord, etc. The zebrafish model also has been used to know the organ 
function assays and assessment of drug effect [84].
Zebrafish embryos are used as predictive model to assess the toxicity in mam-
mals. The lethal concentration (LC50) of different chemicals has been determined 
in embryos of zebrafish and has been compared with the mammalian LC50, and it 
has been found that median lethal dose of zebrafish is lower than mammals [84]. 
The effects of drugs on specific organs have also been studied, and it has been found 
that organ toxicity is similar in both zebrafish and mammals. The drugs that were 
used to evaluate the organ toxicity were gentamicin, cisplatin, vinblastine, quinine, 
neomycin, doxorubicin, dexamethasone, cyclosporin A, caffeine, camptothecin, 
MPA, fluorouracil, etc. [85–90].
4.1 Drug toxicity
In drug development, the toxicity plays a major role. Due to the toxicity problem, 
many new drugs have been declined by the FDA. The evaluation of toxicity of drug 
is very essential to know the end points of toxicity, dose-response relationships, and 
mechanism of toxicity and also to determine the toxicodynamics of the drug [91].
The zebrafish is acquiring the reputation rapidly as a promising model animal 
to study drug and chemical toxicology [92, 93]. The toxicity of some of the impor-
tant drugs has been examined using the zebrafish model, for instance, Amanuma 
et al. [94] developed a test in which susceptible zebrafish was used to detect small 
molecule-induced mutagenesis. The embryos of zebrafish were utilized to compare 
the developmental toxicity resulting from the exposure to ethanol or acetaldehyde 
[95]. Toxicity of antirheumatic drug like diclofenac was evaluated by using zebraf-
ish. Now, zebrafish has got the status of a successful animal model to study drug 
toxicity and toxicology caused by environmental contaminants [91].
4.2 Zebrafish and drug discovery
The zebrafish model has been used potentially in drug discovery and to know 
the effects of neurotoxic, ototoxic, and neuroprotectant drugs. The process of drug 
discovery is divided into four main components: screening of lead compounds, 
target identification, target validation, and assay development [96]. The process of 
target identification involves the recognition of target gene or protein which when 
modulated by a drug can have positive effects on the progression of disease. After 
identification of possible target, the validation process of target begins through 
determination of protein function and assessment of the druggability of the target 
[84, 97–99]. Zebrafish has great role in each of these areas of drug discovery.
4.3 Angiogenesis
The angiogenesis has already been discussed earlier in detail in previous sec-
tions on development and cancer. The impact of various proangiogenic compounds 
like simvastatine or penicillamine20 or antiangiogenic compounds like vandetanib 
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or PTK787 can be assessed well and visualized through the development of the 
vascular system in transparent zebrafish embryo [84].
4.4 Cardiotoxicity
In drug development, cardiotoxicity is one of the major concerns. Through the 
transparent zebrafish embryo, various cardiac functions like heart rate, rhythm, 
contraction, circulation, etc. can be assessed directly. It has been demonstrated well 
that toxic effects of ten cardiotoxic agents in zebrafish embryos have similar impact 
as in humans [100]. Treatment with terfenadine and clomipramine caused severe 
impairment of cardiac functions, edema, hemorrhage, arrested heartbeat, and even 
death. These results in zebrafish exhibit similarities with humans [101]. Another 
group of researchers proposed to use a transgenic model for high-throughput test-
ing of small molecules that modulate the heart rate of the zebrafish embryo [102]. 
Thus, zebrafish is a suitable model for preliminary screening of molecules which 
have potential therapeutic or toxic effects.
5. Human disease and zebrafish
Most of the tissues and organs found in humans and zebrafish are the same 
except lungs and prostrate and mammary glands. The cloning of mutated genes 
screened for specific phenotypes in zebrafish has similarities in humans and thus 
serves as model for human disease and to study underlying mechanisms. The first 
human disease identified using zebrafish was a blood disorder involving specific 
defect in hemoglobin production through ALAS2 mutated gene [103].
Many other mutants which show phenotypic similarities to human disease have 
been screened and identified. These include neurological disorders [104], hema-
tological disorder [105, 106], cardiovascular diseases [107], muscle disease [108] 
and cancers [109, 110], Parkinson’s disease [111], anxiety, and posttraumatic stress 
disorder [112].
6. Zebrafish as a model organism for aquaculture species
Among different fish species of interest to aquaculture, zebrafish is genetically 
more tractable. The zebrafish model is used commercially in many areas of aqua-
culture such as in the identification of genes involved in the development of the 
muscles, bones, and fats, the metabolism of nutrients, disease, and stress pathways 
and also behavioral traits. The drugs which affect the physiology of the fishes can 
be tested easily in zebrafish especially their effect on a range of alleles to assess their 
genetic property [113]. Many researches have been done regarding the improve-
ment of diet and their husbandry to improve the growth rate and reduce stress and 
disease in many fish species like gilthead seabream, seabass, rainbow trout, Atlantic 
salmon, tilapia, catfish, cod, etc. [10]. The zebrafish disease models are being used 
in various infections of aquaculture, for instance, tuberculosis and streptococcal 
and salmonella infections [114].
7. Conclusion
Zebrafish is a successful and versatile animal model system, offering a tool 
to model gene function, development of various organ systems, cancer studies, 
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toxicology, drug discovery, human disease and disorders and also in aquaculture, 
etc. because low cost and easy maintenance, transparent embryo, easy manipula-
tion, high fecundity, and rapid embryonic development favor the zebrafish as an 
attractive model for in vivo assays with simplicity and versatility of in vitro assays 
over mammalian models which lack all of these benefits. The future of zebrafish as 
model organism is very bright. In coming years, an increased number of reports are 
expected on the application of zebrafish as an effective bioindicator.
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